Atlas Trials

Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer

Clinical trial NCT00553410 · COMPLETED

Trial details

NCT number
NCT00553410
Sponsor
ETOP IBCSG Partners Foundation
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2007-08-01
Primary completion
2018-04-01
Enrollment
4884

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.